Alembic Pharma enters oncology segment

DSIJ Intelligence / 15 Jul 2017

Alembic Pharma enters oncology segment

On Friday,pharma player Alembic Pharma has entered into the oncology segment by inaugurating anti-cancer manufacturing facility at Panelav, Halol, Gujarat.

On Friday, pharma player Alembic Pharma has entered into the oncology segment by inaugurating anti-cancer manufacturing facility at Panelav, Halol, Gujarat.

Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The company focuses on analgesic, anti-infective, cough and cold therapies.

The manufacturing facility is designed with major equipment imported from Europeand containment control automated standards. With this facility, Alembic Pharma will commence exporting oncology products to the US, North Africa,Middle East, Australia and South Africa.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.